pyrrolidine dithiocarbamate has been researched along with Kahler Disease in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bhaskaran, S; Gupta, A; McCluskey, B; Muñoz, S; Oyajobi, BO; Sharma, R; Williams, PJ | 1 |
1 other study(ies) available for pyrrolidine dithiocarbamate and Kahler Disease
Article | Year |
---|---|
A dominant-negative F-box deleted mutant of E3 ubiquitin ligase, β-TrCP1/FWD1, markedly reduces myeloma cell growth and survival in mice.
Topics: Animals; Apoptosis; beta Catenin; beta-Transducin Repeat-Containing Proteins; Bone Marrow; Bone Marrow Cells; Bortezomib; Caspase 3; Cell Line, Tumor; Down-Regulation; Enzyme Activation; Female; Genes, Dominant; Humans; Mice; Mice, Inbred C57BL; Multiple Myeloma; Mutation; Neoplasm Transplantation; Proteasome Endopeptidase Complex; Pyrrolidines; Stromal Cells; Thiocarbamates; Tumor Necrosis Factor-alpha; Ubiquitin-Protein Ligases | 2015 |